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Members of the caspase cysteine-protease fam-
ily can be activated by a variety of death-inducing 
agents to cleave death-related cellular proteins, 
thereby initiating programmed cell death. The 
caspases also serve other nonapoptotic cellular 
functions, of whose physiological significance 
and  mechanisms  little  is  known  (Lamkanfi   
et al., 2007).
The epidermal keratinocytes of the skin are 
programmed to undergo spontaneous cell death 
while progressing along their pathway from the 
basal layer of the epidermis, a process which re-
sults in formation of the skin’s cornified layer 
(Candi et al., 2005). These cells express all the 
known caspases and can be induced by ligands 
of the TNF family to die in a caspase-dependent 
manner. Activation of this caspase-mediated cell 
death process apparently contributes to patho-
logical damage of the epidermis in conditions 
such as toxic epidermal necrolysis (Viard et al., 
1998), sunburn (Zhuang et al., 2000), eczematous 
dermatitis (Trautmann et al., 2000), and skin 
ulceration caused by parasitic infection (Eidsmo 
et al., 2005) or Pemphigus foliaceus (Li et al., 
2009). Whether the apoptotic caspases also me-
diate the nonpathological cell death process that 
causes cornification has been a matter of con-
troversy. Early studies suggested that caspase-3 
is proteolytically processed and activated in the 
cornifying epidermis and that this activation is 
required for the programmed death of cells as-
sociated  with  the  cornification  (Weil  et  al., 
1999; Allombert-Blaise et al., 2003). In subse-
quent studies, however, such activation could not 
be confirmed, nor could processing of caspase-6 
or -7 be discerned in the differentiating epidermal 
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Expression of enzymatically inactive caspase-8, or deletion of caspase-8 from basal epider-
mal keratinocytes, triggers chronic skin inflammation in mice. Unlike similar inflammation 
resulting from arrest of nuclear factor B activation in the epidermal cells, the effect 
induced by caspase-8 deficiency did not depend on TNF, IL-1, dermal macrophage function, 
or expression of the toll-like receptor adapter proteins MyD88 or TRIF. Both interferon 
regulatory factor (IRF) 3 and TANK-binding kinase were constitutively phosphorylated in 
the caspase-8–deficient epidermis, and knockdown of IRF3 in the epidermis-derived cells 
from these mice abolished the expression of up-regulated genes. Temporal and spatial 
analyses of the alterations in gene expression that result from caspase-8 deficiency reveal 
that the changes are initiated before birth, around the time that cornification develops, 
and occur mainly in the suprabasal layer. Finally, we found that caspase-8–deficient keratino-
cytes display an enhanced response to gene activation by transfected DNA. Our findings 
suggest that an enhanced response to endogenous activators of IRF3 in the epidermis, 
presumably generated in association with keratinocyte differentiation, contributes to the 
skin inflammatory process triggered by caspase-8 deficiency.
© 2009 Kovalenko et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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fication of such signaling by the absence of caspase-8 contrib-
utes to the chronic skin inflammation caused by caspase-8 
deficiency in the epidermis.
RESULTS
Mice expressing enzymatically inactive caspase-8 develop 
inflammation in various organs, including skin
To investigate structure–function relationships for the various 
effects of caspase-8 in vivo, we used bacterial artificial chro-
mosome (BAC)–mediated transgenesis to produce mice that 
express, besides their endogenous caspase-8 alleles, an addi-
tional copy of the caspase-8 gene or various mutants thereof 
(Fig. 1 A and not depicted; Kang et al., 2008). These trans-
genes were expressed ubiquitously and manifested the same 
tissue-specific expression pattern as that observed for the endog-
enous gene (Fig. 1 B).
Mice that expressed, in addition to the endogenous caspase-8 
alleles, an active site mutant of the protein devoid of enzymatic 
activity (Casp-8+/+/BAC-C362S) appeared normal. However, de-
letion of one of the two endogenous caspase-8 alleles from these 
mice (Casp-8+//BAC-C362S) resulted in their development of a 
chronic inflammatory skin disorder. Cutaneous lesions charac-
terized by focal thickening and scaling appeared 3–5 d after 
birth and gradually spread, covering large areas (Fig. 1 C). His-
tological analysis of the lesions revealed extensive epidermal 
hyperplasia and marked inflammatory cellular infiltration of 
the dermis (Fig. 1 D). Further examination revealed that leu-
kocytes had also infiltrated various internal organs including 
lung, pancreas, and pleura (Fig. 1 E, arrows).
Specific deletion of caspase-8 from epidermal keratinocytes 
results in a similar skin disorder
To examine whether the cutaneous abnormality caused by the 
expression of enzymatically inactive caspase-8 reflects a func-
tional role of this enzyme in the epidermal cells themselves, we 
crossed mice carrying a conditional caspase-8 allele with mice   
expressing Cre under control of the keratin 5 (K5) promoter. In 
this way, we obtained mice in which caspase-8 expression was 
specifically eliminated in the keratinocytes (Fig. 2, A and B). 
The progeny (Casp-8F/K5-Cre) appeared normal at birth but, 3 
d later (i.e., at postnatal day 3 [P3]), began to develop a skin   
disease similar to that of the Casp-8+//BAC-C362S mice (Fig. 2 C). 
They failed to thrive and died by P7. Consistently with the 
known activity of the K5 promoter in the squamous mucosa of 
the stomach, some of the mice also exhibited severe gastric   
inflammation (Fig. S1). However, death of the mice did not 
correlate with the occurrence of gastritis or with decreased food 
uptake and thus was apparently the result of another cause.
The skin in affected sites of the Casp-8F/K5-Cre mice dis-
played pronounced epidermal hyperplasia, as well as orthoker-
atotic and milder parakeratotic hyperkeratosis with loss of the 
stratum granulosum. Intraepidermal pustules were not uncom-
mon and numerous cells were dyskeratotic (Fig. 2, D and E).
Epidermal hyperplasia was restricted to sites of inflamma-
tion (Fig. 3 A). In the dermis these sites exhibited severe dif-
fuse infiltration of inflammatory cells, including eosinophils, 
cells (Lippens et al., 2000; Rendl et al., 2002). More recent 
evidence points to a role for caspase-3 in controlling the rate 
of differentiation of the epidermal keratinocytes during em-
bryonic development (Okuyama et al., 2004). This function, 
however, appears to be independent of the role of this en-
zyme in death induction and does not seem to involve its pro-
teolytic processing (Fischer et al., 2005). The only caspase 
shown conclusively to participate in the cornification process 
is caspase-14, which is quite selectively expressed and acti-
vated in the differentiating and cornifying layers of the epider-
mis and the hair follicles. Its participation, however, does not 
occur through activation of an apoptotic process and is not 
needed for the cornification itself but rather for associated 
processes such as hydration of the skin via proteolytic process-
ing of filaggrin into free hygroscopic amino acids (Denecker 
et al., 2008).
Caspase-8 is known mainly for its role as the proximal 
caspase in the cell death pathway activated by receptors of   
the  TNF/NGF  family.  In  this  paper,  we  show  that  this   
enzyme  is  not  required  for  the  differentiation-associated 
death of the epidermal keratinocytes. However, its deficiency 
in these cells disrupts epidermal homeostasis and triggers a   
severe cutaneous inflammation associated, as in other inflam-
matory skin diseases, with aberrant epidermal growth and 
differentiation.
Generation of inflammatory mediators in the epidermis is 
shown in this study to be initiated before birth and indepen-
dently of the adapter proteins for the toll-like receptors 
(TLRs), ruling out the possibility that the triggering involves 
either pathogen-associated molecular patterns (PAMPs) or 
new antigens to which the mice become exposed upon birth. 
Participation of a trigger that is endogenous to the keratino-
cytes is further indicated by our data showing that the inflam-
mation is largely independent of dermal macrophages. We 
also show that the inflammation is independent of the major 
inflammatory mediators TNF, IL-1, and IL-1, thus differ-
ing from a similar disease caused by arrest of the canonical 
NF-B activation pathway in the keratinocytes that crucially 
depends on TNF and on macrophage function (Pasparakis et al., 
2002; Gugasyan et al., 2004; van Hogerlinden et al., 2004; 
Omori et al., 2006; Sayama et al., 2006).
We present evidence that an IFN regulatory factor (IRF) 3 
activation pathway is constitutively activated in the caspase-8–
deficient epidermis and that, consistently, the genes that are 
overexpressed  in  this  enzyme-deficient  epidermis  include   
many that are known to be IRF3 dependent. Our spatial 
analysis of the expression of inflammatory genes in the caspase-
8–deficient epidermis indicated that its location is largely supra-
basal, suggesting that the trigger for its activation is related to 
the differentiation/cornification process. We found, more-
over, that transfection of caspase-8–deficient keratinocytes 
with DNA triggers activation of these genes more effectively 
than in caspase-8–expressing cells. These findings lead us to 
suggest that certain endogenous activators of the response to 
foreign nucleic acids are generated in the epidermis, possibly 
in association with the cornification process, and that ampli-JEM VOL. 206, September 28, 2009 
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Figure 1.  Mice expressing an enzymatically inactive caspase-8 transgene develop a skin disorder. (A) PCR genotyping of the caspase-8 BAC 
transgenes. Left, genotyping of WT mice and of mice expressing the WT caspase-8 transgene and either WT or KO endogenous caspase-8 alleles. Right, 
restriction analysis distinguishing the enzymatically inactive caspase-8 transgene (BAC-C362S) from WT (BAC-WT) transgene and endogenous allele. The 
arrow points to the HindIII fragment specifically generated in the BAC-C362S transgene. (B) Western blot analysis of caspase-8 in Casp-8+/+/BAC-WT trans-
genic mouse tissues, relative to the WT (right and left lanes, respectively, for each pair), demonstrating its increased expression in all transgenic mouse 
tissues (top). Internal ribosome entry site (IRES)–aided expression of GFP cDNA (inserted into the BAC under control of the caspase-8 promoter) is pro-
portional to that of endogenous caspase-8 (middle). Immunoblot analysis of -actin confirmed equal loading of tissue extracts from the two mice (bottom). 
(C) General appearance of control and transgenic mice. At P5, pallor and thickening in the interscapular area and dorsally at the caudal head indicate 
early lesions. At P14, the mutant is markedly smaller, with scaling, loss of hair, and a small lesion on the left thigh. Lesion distribution is multifocal and 
random. (D) Microscopy of the skin. At P0, skin samples from WT and mutant mice are similar. At P7, the latter demonstrate epidermal hyperplasia and 
multifocal dermal inflammatory cellular infiltration. Hematoxylin and eosin (H&E); Bars, 100 µm. (E) Transgenic mouse specimens demonstrate multifocal 
cellular inflammatory infiltration in diaphragmatic parietal pleura, lung visceral pleura, and interstitium of pancreas and lung (arrows). Bars, 100 µm. The 
data presented in B, C, D, and E are representative of analyses of four, five, three, and three mice, respectively.2164 ROLE OF CASPASE-8 IN THE EPIDERMIS | Kovalenko et al.
To  investigate  the  cellular  function  of  caspase-8  in   
the  cutaneous  epidermal  keratinocytes,  we  first  examined 
whether its deficiency affects cell death, the most thoroughly 
documented function of caspase-8. Cornification seemed un-
harmed. Moreover, outside-in dye penetration tests consistently 
failed to reveal any defect in epidermal barrier function, even 
as late as P7 (unpublished data). No conspicuous aberration 
macrophages, and granulocytes, with no significant increase 
in B lymphocytes (indicated by staining with anti-CD45R 
antibody; unpublished data), and a marked decrease in epi-
dermal CD3+ T lymphocytes (Fig. 3 B). Eosinophils also accu-
mulated within intraepidermal pustules (Fig. 2, B and D; and 
Fig. 3 B). The superficial and follicular epidermis expressed 
K6 specifically in affected areas (Fig. 3 A).
Figure 2.  Epidermis-specific KO of caspase-8. (A) Quantitative assessment of WT and deleted caspase-8 alleles in Casp-8F/K5-Cre mice by genomic 
PCR. (B) X-gal staining for -galactosidase activity in the skins of ROSA26-reporter Casp-8F/+K5-Cre (F/+) and ROSA26-reporter Casp-8F/K5-Cre (F/) 
mice, demonstrating specific Cre-induced recombination in the superficial and follicular epidermis and hair follicles. Bars, 50 µm. (C) General appearance 
of Casp-8F/+K5-Cre and Casp-8F/K5-Cre mice at P7. The mutant is much smaller than the WT. The skin is unevenly thickened with marked alopecia and 
hyperkeratosis. (D) Microscopy of the skin. At P0, the skin of the Casp-8F/K5-Cre mice is indistinguishable in appearance from the skin of the Casp-
8F/+K5-Cre mice. At P7 there is marked epidermal hyperplasia and widespread dermal inflammatory cellular infiltration in the Casp-8F/K5-Cre mouse. 
Arrows in B and D point to intraepidermal eosinophilic pustules. H&E; Bars, 50 µm. (E) The affected epidermis contains numerous dyskeratotic foci, con-
sisting of maloriented keratinocytes often forming a whorl around a central keratinocyte which has become prematurely keratinized (arrows). H&E; Bars, 
50 µm. The data presented in B, C, D, and E are representative of analyses of 4, 350, 30, and 30 mice, respectively.JEM VOL. 206, September 28, 2009 
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function in vivo (Tunggal et al., 2005). Terminal transferase-
mediated dUTP nick-end labeling (TUNEL) revealed no de-
crease and, at a late stage of the pathology, a substantial increase 
was observed in the expression or localization of E-cadherin 
(Fig. S2), the major mediator of intracellular adhesion in epi-
thelial tissues and an essential contributor to epidermal barrier 
Figure 3.  Assessment of inflammation in the skin of Casp-8F/K5-Cre mice. (A) Multifocal cutaneous inflammation at P5. To allow continuous 
viewing of the transition area between inflamed and unaffected skin, two overlapping images of adjacent regions in a skin section covering such an area 
were obtained, and a panoramic image was then constructed using a conventional Photoshop (Adobe) Photomerge routine. The broken line marks the site 
at which the two pictures were merged. The line of dots in the top indicates the approximate location of the transition point. The micrographs demon-
strate epidermal hyperplasia, as well as increased dermal cellularity in the inflamed skin (top, H&E) as a result of infiltration of eosinophils and F4/80-
positive cells (mononuclear phagocytes, middle). Interfollicular expression of K6, which is indicative of epidermal hyperproliferation (bottom), is restricted 
to the thickened epidermal region. Bars, 100 µm. (B) Staining for macrophages (anti-F4/80 antibody), eosinophils (phenol red uptake), granulocytes (anti–
Gr-1 antibody), and T lymphocytes (anti-CD3 antibody) in skin sections from Casp-8F/+K5-Cre and Casp-8F/K5-Cre mice at P7. Note that eosinophils also 
accumulate within pustules in the epidermis of the Casp-8F/K5-Cre mice (also marked by arrows in Fig. 2, B and D). Bars, 100 µM. (C) TUNEL staining 
(top) for assessing apoptosis and Ki67 staining (bottom) for determining cell proliferation rates in the Casp-8F/+K5-Cre and Casp-8F/K5-Cre epidermis at P7. 
Fine broken lines delineate approximate contours of the epidermis. Scale bar, 50 µm. The data presented in A, B, and C are representative of analyses of 
10, 20, and 4 mice, respectively.2166 ROLE OF CASPASE-8 IN THE EPIDERMIS | Kovalenko et al.
Figure 4.  Spatial analysis of the effects of caspase-8 deficiency on protein and gene expression in the epidermis. (A) Immunohistochemical 
characterization of the caspase-8–deficient epidermis. At P7 (right), immunostaining shows expression of the basal layer marker K14 throughout the 
Casp-8F/K5-Cre epidermis. Staining for the intermediate (K1 and involucrin [Inv]) and late (filaggrin [Fila] and loricrin [Lori]) differentiation markers 
shows either their disorganized localization or their almost complete absence in the Casp-8F/K5-Cre lesion areas. Also shown is the ubiquitous expression of JEM VOL. 206, September 28, 2009 
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K6, a general marker for epidermal hyperproliferation. None of these changes was discernible at P0 (left) or P1 (not depicted). Bars, 100 µm.  
(B and C) In situ hybridization for spatial analysis of up-regulated inflammatory genes in the caspase-8–deficient epidermis. Skin samples of Caspase-8F/ 
K5-Cre and Caspase-8F/+K5-Cre littermates at P0 and P7 were hybridized with DIG-labeled antisense RNA probe for mRNA of S100a9 (B) or IL33 (C) and 
then subjected to fluorescence detection (Cy2–anti-DIG, green). Nuclei were counterstained with Hoechst 342 (blue). Rabbit anti-laminin was used to 
visualize the basal membrane (red), highlighted in the magnified presentation of the insets by dotted lines and detected with Cy3-anti–rabbit Ig. Bars, 50 µm. 
The data presented in A, B, and C are representative of analyses of 10, 5, and 5 mice, respectively.
 
of death in the caspase-8–deficient epidermis, mainly in its 
suprabasal layers (Fig. 3 C, top). Assessment of the cell prolif-
eration rate by staining for the Ki67 antigen (Fig. 3 C, bottom) 
or by bromodeoxyuridine incorporation (not depicted) dis-
closed considerably enhanced proliferation of keratinocytes 
in  the  basal  layer.  Ki67-positive  cells  were  also  found  in 
abundance suprabasally.
Immunohistological analysis of the caspase-8–deficient 
skin revealed aberrations of the expression patterns of proteins 
that characterize distinct steps in keratinocyte differentiation, 
a common observation in acute cutaneous inflammation. 
Whereas normally the expression of K14 is restricted to the 
basal layer, in our mutant mice it was also expressed supra-
basally (Fig. 4 A). Moreover, the expression of proteins that 
mark the intermediate (K1) and late differentiation stages (lo-
ricrin and filaggrin) was considerably reduced. The reduction 
was progressive to the extent that in the lesions of P7 mice 
those proteins were barely discernible (Fig. 4 A). The defi-
ciency of filaggrin in the epidermis of these mice seemed 
consistent with the scaly skin and loss of the granular layer, 
two characteristic features of human skin pathologies result-
ing  from  loss-of-function  mutations  of  the  filaggrin  gene 
(McGrath, 2008).
Gene expression analysis reveals that visible pathological 
changes in the skin are preceded by prenatally initiated 
generation of inflammatory mediators in the epidermis
In seeking clues to the molecular changes underlying the in-
flammatory process in the skin and its trigger, we compared 
patterns of gene expression in the skin of Casp-8F/K5-Cre 
and WT mice at different times before and after birth. Numerous 
genes were found to be up-regulated in the Casp-8F/K5-Cre 
skin, most of them in the epidermis. The up-regulated genes 
included several groups encoding proteins that play a role in 
inflammation (Fig. 5 A), and nearly half were genes encod-
ing proteins shown to be induced during epidermal wound 
healing in neonatal mice (WHA; Cooper et al., 2004). A 
rather large subgroup of the up-regulated genes were encod-
ers of proteins known to participate in the IFN response 
(Fig. 5 A and Fig. S3) and to depend on activation of the 
transcription factor IRF3 (Grandvaux et al., 2002; Andersen 
et al., 2008).
Kinetic analysis disclosed that although initial signs of the 
pathological change in the skin could be discerned only at 
about P3, expression of many of the induced genes was en-
hanced in the Casp-8F/K5-Cre epidermis before that time. 
Some were found to be elevated prenatally, 1 d (Fig. 5, B and C 
[D-1]) and even 2 d (not depicted) before birth.
Cultured keratinocytes derived from the Casp-8F/K5-Cre 
mouse epidermis generate inflammatory mediators,  
but the generation gradually abates
To examine the mechanism underlying the up-regulation of 
inflammatory genes in the Casp-8F/K5-Cre epidermis, we 
tried to establish whether this up-regulation occurs autono-
mously in the caspase-8–deficient keratinocytes or depends 
on extracellular stimuli. By applying gene array analysis, we 
found that some of the inflammatory genes that were up-
regulated in the Casp-8F/K5-Cre epidermis were still acti-
vated in keratinocytes derived from that epidermis shortly 
after their culture was initiated. However, in the course of 
passaging  of  the  cells  this  increased  expression  gradually 
abated (Fig. 5 A, KCE versus KCL). These findings suggested 
that in addition to the caspase-8 deficiency in the keratino-
cytes, some other molecular determinants that occur in the 
skin and dissipate under our cell culturing conditions con-
tribute to activation of inflammatory genes in these cells.
The disease caused by caspase-8 deficiency in keratinocytes 
is triggered independently of TNF, IL-1, the TLR adapter 
proteins, or macrophages
Cells of the immune system and mediators generated by 
them play crucial roles in various inflammatory skin disorders 
of humans and in their experimental models (Kupper and 
Fuhlbrigge, 2004). This is true for an inflammatory skin disor-
der that was described in mice with mutations preventing the 
expression or activation of NF-B transcription factors in kera-
tinocytes (Pasparakis et al., 2002; Gugasyan et al., 2004; van 
Hogerlinden et al., 2004; Omori et al., 2006; Sayama et al., 
2006) and that closely resembles the one seen here in Casp-
8F/K5-Cre mice. The former disorder was found to be fully 
dependent on accumulation of macrophages in the dermis, as 
well as on TNF whose expression in the macrophages is high 
(Pasparakis et al., 2002; Omori et al., 2006). To determine 
whether TNF or some other macrophage-produced mediator 
is also responsible for triggering the skin disease in the Casp-
8F/K5-Cre mice, we first assessed the effect of deletion of the 
TNF or the TNFR1 gene from these mice by crossing them 
with the corresponding KO mouse strains. Such deletion dra-
matically increased survival of the offspring (Fig. 6 B and not 
depicted). Their skin disease was not prevented, however, but 
only delayed for a few days. In fact, because these mice survived 
and their skin condition kept worsening, disease severity even-
tually exceeded that seen in the TNF-proficient Casp-8F/K5-
Cre mice (Fig. 6 A and not depicted). Histologically, late-stage 
disease in TNF/Casp-8F/K5-Cre mice was characterized 
by widespread and severe dermal fibrosis, adnexal loss, and 2168 ROLE OF CASPASE-8 IN THE EPIDERMIS | Kovalenko et al.
tion of the TNFR2 gene in addition to TNFR1 caused no fur-
ther delay in onset of the skin disorder (unpublished data).
Like the limited effect of TNF deficiency on development 
of the skin disease, the absence of TNF had little effect on 
gene expression in the epidermis. It resulted only in moderation 
persistence of melanin pigment in the dermis, either in melano-
cytes or in melanophages, after adnexal destruction (pigmentary 
incontinence; Fig. 6 C). Cutaneous scarring was of such a mag-
nitude that it led to severe contraction and rigidity of the skin, 
causing the mice to be in permanent kyphosis (Fig. S4). Dele-
Figure 5.  Expression-profiling analysis of the Casp-8F/K5-Cre skin. (A) Functional groups of genes overexpressed in caspase-8 KO skin. Total RNA 
was extracted from the dermis (Der) or epidermis (Epi) or from cultured keratinocytes at the first and third passages (KCE and KCL, respectively) derived 
from Casp-8F/K5-Cre and Casp-8F/+K5-Cre mice at P3. Epidermal or dermal total RNA from two or three mice of each genotype was pooled for genome-
wide expression analysis using Agilent microarrays (see Materials and methods). Ratios of mRNA expression in Casp-8F/K5-Cre and Casp-8F/+K5-Cre 
samples are presented as heat maps with the corresponding values recorded in the cells. Depicted ratios from keratinocyte samples (KCE and KCL) repre-
sent geometric mean values from two microarray experiments. The 100 most strongly up-regulated genes in the caspase-8–deficient mouse epidermis at 
P3 were depicted and categorized into functional groups according to published references. In addition to the flagged spots, defined as described in 
Materials and methods, we also excluded Y-chromosomal and poorly annotated transcripts from the list. WHA, genes previously found to be induced during 
epidermal wound healing in neonatal mice (Cooper et al., 2004). (B and C) Kinetic analysis of gene-expression changes in the caspase-8–null epidermis 
and assessment of their dependence on TNF. (B) RNA isolated from the epidermal tissues of 22 pairs of Casp-8F/+K5-Cre and Casp-8F/K5-Cre mice (from 
eight litters) and from the epidermal tissues of 22 pairs of TNF/Casp-8F/+K5-Cre/TNF/Casp-8F/K5-Cre mice (from seven litters) was used for real-time 
RT-PCR determination of the expression of 15 selected genes representative of most of the functional groups identified in A. For heat map visualization, 
the log2-transformed expression ratios were ordered according to increasing consistency of changes in mRNA expression in the TNF+/+ mice (horizontal 
axis). Percentages of Casp-8F/K5-Cre mice at a given age with a significantly up-regulated transcript relative to its mean expression in all Casp-8F/+K5-Cre 
age-matched mice are recorded in the heat map boxes. n, number of experimental/control mice pairs analyzed for the given age (also see Materials and 
methods). (C) RNA was isolated from the epidermis of Casp-8F/K5-Cre mice (empty circles, values for individual mice born on different dates; broken 
lines, mean values for all individuals analyzed at a particular age) and of Casp-8F+K5-Cre mice (filled circles and solid lines) 1 d before birth (D-1) and 
at different times postnatally. For each mouse, mRNA expression of the indicated four genes was analyzed by real-time PCR. Samples from pairs of 
Casp-8F/K5-Cre and Casp-8F+K5-Cre mice were tested simultaneously; these pairs are depicted at identical horizontal positions. (In the case of Isg15, 
four additional D-1 WT samples were analyzed.) Shown are the  cycle-threshold (Ct) values obtained by subtraction of the Ct value of each PCR prod-
uct from the Ct value of the housekeeping gene Hprt1. Red arrows point to values for two Casp-8F/K5-Cre mice that showed significant up-regulation 
of Isg15 expression before birth.JEM VOL. 206, September 28, 2009 
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Figure 6.  Limited effect of deficiency of TNF, IL-1, or macrophage depletion on cutaneous disease development in the caspase-8–null skin. 
(A) Gross appearance of TNF/Casp-8F/+K5-Cre and TNF/Casp-8F/K5-Cre mice at different ages. (Arrows point to skin lesions at P7 and P30.) There is 
progressive hyperkeratosis, scaliness, and hair loss, with ulceration in some cases (middle). (B) Survival curves for colonies of Casp-8F/K5-Cre (green; 62 mice), 
IL1/IL1/Casp-8F/K5-Cre (yellow; 55 mice), TNF/Casp-8F/K5-Cre (red; 37 mice), and IL1/IL1/TNF/Casp-8F/K5-Cre mice (blue; 42 mice). 
(C) Microscopic features of late-stage disease in a TNF/Casp-8F/K5-Cre mouse at P60. There is diffuse epidermal hyperplasia, dermal fibrosis, adnexal 
loss, and accumulation of melanocytes and melanophages (pigmentary incontinence). H&E; Bar, 100 µm. (D) Microscopic appearance of the skin of IL1/ 
 IL1/TNF/Casp-8F/+K5-Cre and IL1/IL1/TNF/Casp-8F/K5-Cre mice at P7. H&E; Bars, 100 µm. (E) Macrophage content (anti-F4/80 staining, 
left) and microscopic appearance (H&E, right) of the skin of Casp-8F/K5-Cre mice injected with control liposomes (top) and clodronate-containing lipo-
somes (bottom) at P5. Bars, 100 µM. (F) Effect of macrophage depletion on gene expression changes in the Casp-8F/K5-Cre epidermis. To deplete dermal 
macrophages, mice were injected subcutaneously every other day, starting at P0, with clodronate-loaded liposomes or PBS-loaded liposomes (control). RNA 
was isolated from the epidermis at P5 and analyzed for expression of CSF1, a macrophage marker (left), and of four inflammation markers found to be in-
creased in Casp-8F/K5-Cre mice (right). Mean values ± SD for three experimental/control mice pairs are shown. The data presented in A, C, D, E, and F are 
representative of analyses of 10, 4, 7, 15, and 5 mice, respectively. The data in E and F are the results of three independent experiments in both cases.2170 ROLE OF CASPASE-8 IN THE EPIDERMIS | Kovalenko et al.
of gene induction, with no evident change in the pattern of 
the induced genes (Fig. 5 B, compare bottom and top).
An increase in IL-1, which, like TNF, is known to play a 
major role in the induction of inflammation, was reported to 
accompany the cutaneous inflammation that results from the 
arrest of NF-B activation in the epidermis (Pasparakis et al., 
2002). We found that the messenger RNAs (mRNAs) of IL-1 
and IL-1 were also increased in the epidermis of our Casp-
8F/K5-Cre mice (Fig. 5 B and not depicted). However, simul-
taneous deletion of the genes for IL-1 and IL-1 had no effect 
on the skin pathology in these mice (not depicted), nor did it af-
fect their survival (Fig. 6 B). Deletion of these genes from Casp-
8F/K5-Cre mice that were also deficient in TNF led to a slight 
further increase in their survival (Fig. 6 B) but did not alleviate 
the cutaneous inflammation (Fig. 6 D and not depicted).
To determine whether signaling by TLRs contributes 
to the initiation of the skin disease in the Casp-8F/K5-Cre 
mice, we crossed these mice with KO mice for MyD88 and 
for TRIF, which encode two adapter proteins that mediate 
TLR-dependent signaling. Neither the rate nor the extent of 
development of cutaneous inflammation in the Casp-8F/K5-Cre 
mice nor the onset of their death was affected by deficiency 
of either of these proteins (unpublished data).
In mice with an inflammatory skin disease resulting from 
IKK2 deficiency in the keratinocytes, depletion of macro-
phages from the dermis by subcutaneous injection of clodro-
nate-containing liposomes abolished the symptoms (Stratis 
et al., 2006). However, no such effect on the kinetics or extent 
of development of cutaneous inflammation was detectable in 
our  Casp-8F/K5-Cre  mice  (Fig.  6  E  and  not  depicted). 
Moreover, such treatment did not significantly affect either 
the pattern or the extent of changes in gene expression in the 
epidermis (Fig. 6 F and not depicted).
Thus, unlike in the case of the inflammatory skin disease 
that results from deficiency of the NF-B activation pathway 
in keratinocytes, the findings described in this section indi-
cated that triggering of the cutaneous inflammation that re-
sults from caspase-8 deficiency in the Casp-8F/K5-Cre mice 
occurs independently of TNF or of any other mediator pro-
duced by the dermal macrophages. It also does not depend 
on IL-1–induced or TLR-induced signaling.
The skin disease caused by caspase-8 deficiency  
in keratinocytes is associated with constitutive signaling  
for IRF3 activation
Western analysis of IRF3 in the Casp-8F/K5-Cre mouse epi-
dermis revealed that this transcription factor is phosphorylated 
Figure 7.  IRF3 is constitutively activated in the Casp-8F/K5-Cre 
epidermis. (A) Western blot analysis of lysates of the epidermis of two Casp-
8F/+K5-Cre and two Casp-8F/K5-Cre littermates at P3 for phosphorylation of 
TBK1 (ph-TBK1, enriched by immunoprecipitation with anti-TBK antibody) 
and of IRF3 (ph-IRF3), as well as for expression of IRF3 and of the IRF3-
induced protein Isg15, and conjugation of Isg15 to the cellular proteins.  
(B) Western analysis of ph-IRF3, as in A, for mouse littermates at P1. As illus-
trated, the small amount of ph-IRF3 in the lysates of the Casp-8F/K5-Cre 
epidermis at that date could be discerned only when the cells were lysed  
in the presence of the sulphhydryl blocking agent N-ethylmaleimide.  
(C and D) Activation of inflammatory genes in early passage Casp-8F/K5-Cre 
keratinocytes is dependent on the presence of IRF3. (C) Relative expression 
(means ± SD of the indicated gene transcripts in Casp-8F/K5-Cre mRNA to 
the same transcripts in Casp-8F/+K5-Cre mRNA) assayed in keratinocytes 
from three pairs of P1 littermates that were transfected, 1 d after plating, 
with either control siRNA (blue) or IRF3 siRNA (maroon). (D) Western analysis 
of the effect of IRF3 siRNA transfection on IRF3 expression and on expres-
sion of Isg15 in two of the Casp-8F/K5-Cre keratinocyte samples used in  
C. Analysis of the expression of -actin served as a loading control. The data 
presented in panels A, B, C, and D are representative of findings obtained in 
three, two, four, and four independent experiments, respectively.
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DISCUSSION
Caspase-8 is known mainly for its role in the induction of cell 
death. Our investigation of the effect of caspase-8 deficiency 
on the epidermis disclosed no decrease in the effectiveness of 
the cornification. This finding is consistent with the results of 
several earlier studies that cast doubt on the supposition that 
caspases participate in the programmed cell death process that 
causes cornification (Lippens et al., 2000; Rendl et al., 2002; 
Fischer et al., 2005). We found, however, that epidermal de-
ficiency of caspase-8 did have a pronounced effect on skin 
homeostasis in that it gave rise to a chronic inflammatory dis-
ease associated with a hyperproliferative state. In a previous 
study we found that caspase-8 deficiency in hepatocytes pro-
motes chronic inflammation in the liver after partial hepatec-
tomy (Ben Moshe et al., 2007, 2008). The present study 
shows that widespread inflammation also develops in mice 
that express an enzymatically inactive caspase-8 allele. Col-
lectively, these findings suggest that apart from its roles in 
mediating death and, in certain tissues, also growth and sur-
vival, caspase-8 also acts to restrict inflammation.
As yet, little is known of mechanisms that underlie non-
apoptotic  functions  of  caspase-8.  Nevertheless,  there  are 
some clues to the mechanism responsible for the nonapop-
totic function of caspase-8 described in the present study. We 
previously reported that death induction by caspase-8 is com-
promised in BAC transgenic mice in which the aspartate resi-
due upstream of the initial self-processing site in caspase-8 is 
mutated, yet these mice show no overt pathology in the skin 
or other tissues (Kang et al., 2008). Thus, unlike the apop-
totic function of caspase-8, and similarly to various nonapop-
totic functions of this enzyme, processing of caspase-8 is not 
required for its antiinflammatory activity. However, our 
present finding that the mere expression of an enzymatically 
inactive caspase-8 allele causes inflammation in the skin and 
in other tissues, apparently because of its interference with 
the function of coexpressed enzymatically active caspase-8 
molecules, suggests that the restriction of inflammation by 
this enzyme, even though it is independent of its self-process-
ing, does depends on its enzymatic activity. Moreover, the 
dominant-negative effect of the inactive molecules on the 
function of the enzymatically active coexpressed molecules 
suggests that the mechanism by which caspase-8 restricts in-
flammation depends, as in the case of caspase-8 induction of 
cell death, on the association of two or more caspase-8 mole-
cules with one another.
Although caspase-3 reportedly also contributes to devel-
opment of the epidermis through a function that is not apop-
totic, this contribution, unlike that of caspase-8, takes place 
only prenatally (Okuyama et al., 2004). The fact that the skin 
of capase-3–deficient mice is normal in appearance (Leonard 
et al., 2002) further suggests that the functional role of cas-
pase-3 in the epidermis is distinct from that of caspase-8. Yet 
another caspase, caspase-14, serves an important role in con-
trolling  epidermal  differentiation  (Denecker  et  al.,  2007). 
However, we observed no deficiency in expression or pro-
cessing  of  caspase-14  in  the  caspase-8–deficient  epidermis 
as early as P1 (Fig. 7, A and B). Moreover, the Casp-8F/K5-Cre 
epidermis was found to contain the phosphorylated form of 
TANK-binding kinase (TBK; TBK1), which is known to 
activate IRF3 (Fig. 7 A), and to have heightened expression of 
Isg15 (Fig. 7 A), an IRF3-dependent ubiquitin-related poly-
peptide. This was consistent with our finding that the Isg15 
gene was activated in the Casp-8F/K5-Cre mice epidermis 
even before birth (Fig. 5, A–C). The analysis also revealed en-
hanced conjugation of this polypeptide to cellular proteins, a 
hallmark of the antiviral response (Sadler and Williams, 2008). 
Although expression of the IRF7 transcript was also enhanced 
in the Casp-8F/K5-Cre epidermis, Western analysis of these 
epidermal cells failed to show any expression of the IRF7 pro-
tein in them (unpublished data).
Knockdown of IRF3 in cultured Casp-8F/K5-Cre kera-
tinocytes abolished the up-regulation of Isg15, as well as the 
activation of three out of five other tested genes chosen from 
those which were still up-regulated in these cells after they 
were plated for culturing (Fig. 7, C and D). These findings 
indicated that the constitutive activation of IRF3 in the Casp-
8F/K5-Cre epidermis contributes to the up-regulation of in-
flammatory mediators in the epidermal cells.
Generation of inflammatory mediators in the epidermis 
occurs mainly in its suprabasal layer
In seeking clues to the nature of the endogenous stimulus 
that triggers gene up-regulation in the epidermis, we applied 
in-situ hybridization to determine the epidermal site at which 
two of the most strongly up-regulated genes, those encoding 
the alarmin S100a9 and the cytokine IL33, are activated. As 
shown in Fig. 4 (B and C), although caspase-8 deletion is in-
duced in the basal cell layer of the epidermis, neither of these 
genes was expressed at that site but rather was expressed in 
the higher layers. Expression of S100a9 could also be dis-
cerned in some distinct cells in the dermis. These findings 
suggested that activation of inflammatory genes in the epider-
mis of the Casp-8F/K5-Cre mice is triggered by molecular 
changes that occur suprabasally.
Gene activation by transfected DNA is enhanced in caspase-
8–deficient keratinocytes
To examine the possibility that damage-associated molecular 
patterns (DAMPs) generated during cornification contribute 
to the induction of skin inflammation, we attempted to re-
produce the effect of DNA that might be released to the 
cytoplasm when the nuclei of the cornifying cells break up. 
We did this by transfecting caspase-8–deficient keratinocytes 
with DNA. As shown in Fig. 8 (A and B), both knockdown 
of caspase-8 in vitro and KO of the caspase-8 gene in vivo 
significantly enhanced the induction of inflammatory cyto-
kines in the cultured DNA-transfected keratinocytes. Ex-
pression of the Isg15 protein was also greatly enhance in 
these cultures (Fig. 8 C). These findings indicate that cas-
pase-8 deficiency facilitates the cellular response to foreign 
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Figure 8.  Caspase-8–deficient keratinocytes display an enhanced response to transfected DNA. (A and B) Effect on gene activation. (A) Effect of 
caspase-8 knockdown. Relative expression of the IFN gene (ratio of the IFN- transcript in caspase-8 knockdown keratinocytes to the same transcripts 
in mock-transfected cells) assayed in keratinocytes from one pair of P1 littermates that were transfected in duplicate, 1 d after plating, with either con-
trol siRNA (blue) or caspase-8 siRNA (maroon) and, 72 h later, transfected with poly(dA-dT) for the indicated times. Shown are mean expression ratios ± 
SD for the respective duplicate transfections. (B) Effect of caspase-8 KO. Expression of the indicated gene transcripts at different times after DNA trans-
fection of keratinocytes from Casp-8F/+K5-Cre mouse and Casp-8F/K5-Cre mouse epidermis from two pairs of P1 littermates, 1 d after plating. Cells were 
transfected either with poly(dA-dT) or with calf thymus DNA, as described in Materials and methods. (C) Effect on Isg15 expression. Western analysis of 
the expression of Isg15 protein at different times after poly(dA-dT) transfection of keratinocytes from Casp-8F/+K5-Cre and Casp-8F/K5-Cre epidermis 
from two pairs of P1 littermates, 1 d after plating, as in A. Analysis of the expression of -actin served as a loading control. The data presented in each 
of the panels are representative of findings obtained in two independent experiments.JEM VOL. 206, September 28, 2009 
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(Fig. S5), suggesting that the function of caspase-8 in the epi-
dermis is also distinct from that of caspase-14.
To obtain further clues to the mechanisms underlying the 
inflammation caused by caspase-8 deficiency, as well as to 
suggest potential treatments for skin diseases that might be 
related to that deficiency, it is important to identify the agents 
that trigger this inflammation. TNF is known to play a role in 
the pathogenesis of psoriasis, a skin disease that in some re-
spects resembles the disease seen in our mice (Schottelius et al., 
2004); in addition, this cytokine is critically involved in a skin 
disease of mice with epidermal-specific deletion of genes en-
coding proteins that participate in NF-B activation (Pasparakis 
et al., 2002; Gugasyan et al., 2004; van Hogerlinden et al., 
2004; Omori et al., 2006; Sayama et al., 2006). We therefore 
investigated the extent to which TNF contributes to the skin 
inflammation caused by caspase-8 deficiency. Our results 
showed that although TNF expression facilitates development 
of the disease, it is not crucial for it. We further established 
that IL-1 and IL-1, both of which are prominent players in 
a variety of inflammatory diseases, do not contribute to the 
mouse cutaneous inflammation. Notably, this last finding re-
futes the recent suggestion that the induced generation of IL-1 
mediates the inflammatory skin disease inflicted by caspase-8 
deficiency in the epidermis (Lee et al., 2009). In further dis-
agreement with mechanisms suggested in that study, we also 
found that this disease was not affected when the mice were 
injected with a pharmacological inhibitor of the p38 MAP 
kinase (SB203580; unpublished data), which was suggested by 
those authors to trigger the generation of IL-1. In addition, 
pharmacological depletion of macrophages accumulating in 
the dermis in both diseases, which protects against the disease 
caused by interference with NF-B activation (Stratis et al., 
2006), had no effect on our mice. It thus appears that whereas 
the disease caused by interference with NF-B activation de-
velops through a dialogue between the keratinocytes and cells 
of the immune system, the disease caused by caspase-8 defi-
ciency in the keratinocytes reflects a cell-autonomous function 
of these epidermal cells.
We found that IRF3 and TBK1 (a protein kinase that 
participates in IRF3 activation) are constitutively phosphory-
lated in the epidermis of the Casp-8F/K5-Cre mice and that 
genes known to be induced by IFN and IRF3 are activated 
in the epidermis. Phosphorylated IRF3 could be discerned in 
the epidermis as early as P1, significantly before any patho-
logical change became apparent (the limited sensitivity of 
western analysis precluded earlier assessment), strongly sug-
gesting that the phosphorylation is a cause rather than a con-
sequence of the disease.
IRF3 is known to be activated by extracellular molecular 
patterns  associated  with  pathogens  (PAMPs).  In  addition, 
cells possess mechanisms that also allow this transcriptional 
factor to be activated in response to intracellular molecular 
patterns associated with pathogens, or with the molecular 
changes resulting from cell damage (DAMPs). Some endoge-
nous cellular components can activate these mechanisms even 
in the absence of pathogens (Chi and Flavell, 2008; Okabe 
et al., 2008; Stetson et al., 2008). Because the disease in our 
Casp-8F/K5-Cre mice became apparent only a few days after 
birth (even though the gene deletion dictated by the expres-
sion of Cre under the K5 promoter occurs prenatally), it 
would have been reasonable to suspect that it was triggered 
by antigens and PAMPs, to which the mice were exposed for 
the first time after birth. This possibility, however, was ruled 
out by our findings that the generation of inflammatory me-
diators in the epidermis begins before birth and that the dis-
ease was not affected by deletion of MyD88 or TRIF, genes 
encoding the major adapter proteins for the TLRs which sig-
nal for the effects of extracellular PAMPs.
We showed in this paper that caspase-8–deficient keratino-
cytes exhibit enhanced gene activation by transfected DNA. 
Recently, we observed that cells deficient in caspase-8 also re-
spond more effectively to viral RNA and that caspase-8 binds 
to components of the RIG-I signaling complex that mediates 
cellular responses to intracellular foreign ribonucleic acid, sup-
pressing the complex-induced IRF3 activation but having little 
effect on the ability of the complex to activate NF-B (unpub-
lished data). These findings suggest that caspase-8 acts to re-
strain excessive activation of pathways of response to intracellular 
pathogenic components and to DAMPs and that its failure to 
so in the Casp-8F/K5-Cre keratinocytes contributes to the 
triggering of the cutaneous disease in Casp-8F/K5-Cre mice.
The nature of the endogenous cellular components that 
trigger the disease remains to be further defined. This study 
suggested that they are generated suprabasally in the epider-
mis and that their generation is initiated before birth (the 
time at which cornification starts; Mack et al., 2005) and is 
greatly enhanced after birth (when cornification reaches its 
maximal extent). Our findings raise the possibility that gen-
eration of these endogenous activators is associated with the 
differentiation process that leads to the cornification.
MATERIALS AND METHODS
Mice
All experiments in this study were performed with mice on the C57BL/6 
background. Mouse strains carrying a knocked-out caspase-8 allele (Casp8/+ 
[Varfolomeev et al., 1998]) or a conditional caspase-8 allele (Casp8F/+ [Kang 
et al., 2004]) and their use in obtaining tissue-specific deletion of the caspase-8 
gene (Kang et al., 2004) have been described previously. Mice deficient in 
TNF (strain B6; 129S6-Tnftm1Gkl/J), TNF-R1 and TNF-R2 (strain B6; 129S-
Tnfrsf1atm1Imx  Tnfrsf1btm1Imx/J),  or  TRIF  (C57BL/6J-Ticam1Lps2/J 
[Hoebe  et  al.,  2003])  and  the  ROSA26  reporter  strain  (B6.129S4-
Gt(ROSA)26Sortm1Sor/J) were obtained from The Jackson Laboratory. Mice 
expressing Cre under control of the K5 promoter (Ramirez et al., 2004) were 
obtained from J. Jorcano (Centro de Investigaciones Energéticas, Medioambi-
entales y Tecnológicas, Madrid, Spain). Mice deficient in IL-1 and IL-1 
(Yamada et al., 2000) were obtained from Y. Iwakura (Research Institute of 
Tuberculosis, Kiyose, Tokyo), and mice deficient in MyD88 were provided by 
S. Akira (Osaka University, Osaka, Japan). All animal protocols were approved 
by the Ethical Care Committee of the Weizmann Institute of Science.
Antibodies
Rabbit anti-cytokeratin 1, 6, and 14, as well as involucrin, filaggrin, and lo-
ricrin antibodies, were purchased from Covance. Rat anti-F4/80 and anti-
CD3 were obtained from AbD Serotec, rat anti-Ki67 from Dako, rat 
anti–mouse Ly6G (Gr1) from eBioscience, rabbit anti-IRF3, rabbit anti–
mouse Isg15, and anti–caspase-14 from Santa Cruz Biotechnology, Inc., rabbit 2174 ROLE OF CASPASE-8 IN THE EPIDERMIS | Kovalenko et al.
RNA interference
Keratinocytes were plated in 12-well plates at 50,000 cells/well and trans-
fected 1 d later with 500 nmol of small interfering RNA (siRNA) duplex per 
well (Accell; Thermo Fisher Scientific). After 72 h the cells were processed 
for analysis.
DNA transfection
Keratinocytes were transfected either with 1 µg/ml poly(deoxyadenylic-thymi-
dylic) (poly(dA-dT); Sigma-Aldrich) or calf thymus DNA (Sigma-Aldrich) using 
Lipofectamine 2000 (Invitrogen) as specified by the manufacturer.
Real-time PCR
We isolated RNA from epidermis and dermis samples (peeled apart after 
brief heating as described in Western analysis of epidermal proteins) using 
the RNeasy Fibrous Tissue mini kit, and from cultured keratinocytes using 
the RNeasy kit (QIAGEN). 1 µg of total RNA was reverse transcribed into 
complementary DNA (cDNA) using 50 U BioScript RNase H Low (Bio-
line). Aliquots (20 ng, 1:50 dilution) of this reaction mixture were used 
to  amplify cDNAs with Assays-on-Demand (Applied Biosystems) on an 
ABI7500 real-time PCR system. The Ct value for each individual PCR 
product was calculated from duplicate measurements by means of the instru-
ment’s software, and the Ct values obtained were normalized by subtracting 
the Ct values obtained for Hprt1 as a housekeeping gene. The resulting mean 
Ct values from WT or KO mice were then used to calculate relative 
changes of mRNA expression as the ratio (R) of mRNA expression, accord-
ing to the following equation: R(log2) = (mean  Ct(caspase-8/))  
(mean  Ct(WT)). The increase in gene expression for individual KO 
mice was defined as significant if the Ct value obtained for a given gene 
and a given KO mouse was greater than the mean Ct + 2 SD of all 
WT mice of corresponding ages. Heat maps were visualized by importing 
log2-transformed ratio data into the Mayday program (http://www.zbit 
.uni-tuebingen.de/pas/mayday/mayday.html).
Microarray experiments
The Mouse Oligo Microarray V2 (G4121B, design ID 13326; Agilent Tech-
nologies) used in this study contained oligonucleotide probes directed against 
19,307 endogenous mRNAs. RNA was used to prepare Cy3- or Cy5- 
labeled cRNA by oligo-(dT)-T7–primed double-stranded cDNA synthesis 
(cDNA Synthesis System; Roche), followed by in vitro transcription and la-
beling (Amino Allyl MessageAmp II kit; Applied Biosystems) as directed by 
the manufacturer. For the cRNA mixture, the fragment length, yield, and 
labeling efficiency were analyzed by a 2100 Bioanalyzer (Agilent Technolo-
gies)  and  a  NanoDrop  ND1000  spectrophotometer.  cRNA  populations 
(differentially labeled with 3 µg each of Cy3 and Cy5) were combined for 
cohybridization onto a single microarray. cRNA fragmentation, hybridiza-
tion, and washing steps were performed according to Two-Color Microarray-
Based Gene Expression Analysis Protocol V5.0.1 (Agilent Technologies; for 
details see http://www.agilent.com).
Hybridized and washed arrays were scanned on a 428 Array Scanner 
(Affymetrix). Data were extracted using of Imagene V5.0 software (BioDis-
covery). Fluorescence intensity values were normalized according to LOW-
ESS-like calculations. Data from qualitatively suboptimal spots were flagged 
and excluded from further analysis if CVsignal mean > 0.20 or if SMglobal 
background corrected/SMlocal background corrected > 1.3, where CVsig-
nal mean is the coefficient of variance deduced from signal values for all 
pixels of a spot and SMglobal background corrected/SMlocal background 
corrected is the ratio of a global background-corrected signal mean value of 
a spot divided by its local background-corrected signal mean value.
mRNA expression analysis of cultured keratinocytes was performed using 
Mouse Whole Genome 4 × 44k Microarrays (G4122F, design ID 014868; Agi-
lent Technologies). Sample processing, hybridization, data extraction, and nor-
malization were performed exactly as recommended by the manufacturer. The 
microarray-based data discussed in this publication have been deposited at NCBI 
Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) and are 
accessible through GEO Series accession no. GSE17365.
anti-TBK1 and rabbit phospho (ph)-IRF3 from Cell Signaling Technology, 
mouse monoclonal anti–ph-TBK1 from BD, goat anti-TNF from R&D Sys-
tems, anti–mouse caspase-8 from Enzo Biochem, Inc., anti–-actin and anti-
laminin from Sigma Aldrich, and Cy2–anti-DIG and Cy3-anti–rabbit Ig 
from Jackson ImmunoResearch Laboratories. Immunoperoxidase polymer 
anti–rat was obtained from Nichirei.
Depletion of macrophages from the skin
To deplete skin macrophages, we injected the mice subcutaneously, at 10 sites 
over the back, with clodronate-loaded liposomes or, as a control, with PBS-
loaded liposomes (100 µl/mouse; gift of N. van Rooijen, Vrije Universiteit, 
Amsterdam, Netherlands) every second day, starting from the day of birth (P0).
Histology and immunostaining
Skin and other organs were fixed in 10% phosphate-buffered formalin, pH 7.4, 
embedded in paraffin, cut into 4-µm sections, and stained with H&E. Adjacent 
sections were used for immunostaining with the indicated antibodies according 
to the manufacturers’ instructions. For fluorescent detection we used Cy-2– or 
Cy-3–coupled secondary antibodies (Jackson ImmunoResearch Laboratories). 
To visualize nuclei, we further counterstained sections with Hoechst 33342 
(Sigma-Aldrich). For chromogenic detection, sections were stained with 
immunoperoxidase polymer anti–rat antibodies and developed with 3,3-
diaminobenzidine (Sigma-Aldrich) for 10 min. A TUNEL staining kit (Roche 
Diagnostics) was used to detect apoptotic cells. Frozen sections (10-µm thick) 
were stained with X-Gal (5-bromo-4-chloro-3-indolyl-d-galactoside) or with 
phenol red (Ain et al., 2002). All histological and immunohistological analyses 
shown are representative of at least five sections examined.
In situ hybridization
Probe synthesis and in situ RNA hybridization were performed essentially as 
described (Darby and Hewitson, 2006). In brief, 6-µm skin sections were 
prepared from paraffin-embedded tissue blocks. After deparaffinization, slides 
were treated with 10 µg/ml proteinase-K for 15 min, fixed in 4% parafor-
maldehyde, and acetylated. The slides were then hybridized with sense or 
antisense DIG-labeled RNA probe overnight at 65°C. The next day, the 
slides were washed in saline-sodium citrate buffer and incubated with Cy2-
labeled anti-DIG antibody for 1 h at room temperature. The data shown are 
representative of analysis of at least five different sections.
Western analysis of epidermal proteins
The epidermis and dermis were pulled apart after incubation for 2–3 s at 
65°C. Epidermis samples were lysed in RIPA buffer (20 mM Tris-HCl, pH 7.5, 
50 mM NaCl, 0.5% NP-40, 4 mM EDTA, 0.1% SDS, and 0.5% sodium   
deoxycholate) supplemented with 1 mM PMSF, 50 mM NaF, 1 mM so-
dium vanadate, 80 mM -glycerophosphate, and a cocktail of protease in-
hibitors (Roche). For detection of ph-IRF3 in the epidermis at P1, we 
further supplemented the lysis buffer with 1 mM N-ethylmaleimide (Sigma-
Aldrich). This greatly facilitated detection, probably by blocking the func-
tion of some potent protein phosphatases which had remained active in spite 
of the presence of phosphatase inhibitors in the lysis buffer.
Keratinocyte culture
Skin was removed from the mice and incubated overnight at 4°C in 2.4 U/ml 
Dispase (Roche) to separate the epidermis from the dermis. The kerati-
nocytes were then dissociated by incubation of the epidermis for 10 min in 
0.1% trypsin, recovered by centrifugation, and plated on tissue culture dishes 
in keratinocyte serum-free medium containing 50 µg/ml bovine pituitary 
extract and 5 ng/ml of epidermal growth factor (Invitrogen) supplemented 
with antibiotics. For passaging, cells were detached by incubation in PBS 
containing 0.1% trypsin, 0.5 mM EDTA, and 0.1% glucose and replated in 
keratinocyte serum-free medium.
Genotyping of mice
Deletion of caspase-8 from the skins of Casp-8F/K5-Cre and Casp-8F/+K5-
Cre mice was quantitatively assessed by PCR, as previously described (Kang 
et al., 2004).JEM VOL. 206, September 28, 2009 
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tion. After being washed with ethanol, the BAC DNA was dissolved in TE 
buffer, linearized by digestion with PI–SceI endonuclease (NEB), and 
drop dialyzed for 6 h against microinjection buffer (10 mM Tris, pH 7.5, 
0.1 mM EDTA, pH 8.0, and 100 mM NaCl) by floating on a 0.025 µm 
membrane filter disc (Millipore). The quality and quantity of BAC DNA 
were assessed by pulse-field gel electrophoresis (PFEG; 5 V/cm, 120° angle, 
linear ramping time 5120 s for 2430 h) in 1% agarose using the CHEF-
DR III PFEG system (Bio-Rad Laboratories). The DNA was diluted to 
2 ng/µl in microinjection buffer and mixed with an equal volume of 2× 
polyamine (60 mM spermine and 140 mM spermidine in injection buffer) 
for the injection.
Generation and analysis of BAC-transgenic mouse. 1 ng/µl DNA was 
injected  into  the  pronuclei  of  fertilized  oocytes  derived  from  CBF1  or 
C57BL/6 mice. Transgenic mice were identified both by PCR analysis (us-
ing primers Mut CF and IN1-1730R) of genomic DNA prepared from tail 
biopsies and by FACS analysis for GFP expression in peripheral blood leu-
kocytes. Catalytically inactive caspase-8 transgenic mice were distinguished 
from mice harboring active caspase-8 by the use of primers IF2-JR1 for PCR 
followed by digestion with HindIII.
For Western blot analysis of extracts of various tissues of the BAC trans-
genic mice, tissue lysates were prepared by homogenization in lysis buffer 
(1% SDS, 1 mM sodium orthovanadate, and 10 mM Tris, pH 7.4) followed 
by boiling for 5 min. Protein concentration was determined with the BCA 
protein assay kit (Thermo Fisher Scientific). Aliquots of 25 µg of protein 
were then analyzed by SDS–PAGE and immunoblotted with anti–mouse 
caspase-8 (3B10; Enzo Biochem, Inc.), anti-GFP, and anti–-actin mono-
clonal antibodies (Sigma-Aldrich).
Online supplemental material
Fig. S1 shows the gastric inflammation in Casp-8F/K5-Cre mice. Fig. S2 
shows the expression pattern of E-cadherin in the Casp-8F/K5-Cre epider-
mis. Fig. S3 presents an assessment of the expression of several IRF3 target 
genes in the Casp-8F/K5-Cre epidermis. Fig. S4 compares radiographs of 
TNF/Casp-8F/+K5-Cre and TNF/Casp-8F/K5-Cre mice. Fig. S5 shows 
western analysis of the expression of caspase-14 in the Casp-8F/K5-Cre epi-
dermis. Fig. S6 is a diagrammatic presentation of the strategy for BAC modi-
fication  in  this  study.  Table  S1  lists  the  oligonucleotides  used  for  BAC 
transgenesis. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20090616/DC1.
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Modification of a BAC encompassing caspase-8 and generation of 
BAC-transgenic mice
Modification of a BAC encompassing the caspase-8 gene. RP24-
238B22, a BAC clone encompassing the caspase-8 gene (RPCI-24 mouse 
[C57BL/6] BAC library) was obtained from CHORI (BACPAC Resources). 
DH10B bacteria harboring the RP24-238B22 BAC clone were grown in LB 
medium containing 12.5 µg/ml chloramphenicol. The presence of caspase-8 
in the bacterial colonies was verified by PCR using oligonucleotides   
exon8F-8R, exon1F-1R, and 5UTRF-R (the oligonucleotides used are listed 
in Table S1). The BAC clone was modified essentially as previously de-
scribed (Gong et al., 2002; Sparwasser et al., 2004) using the pDelsac shuttle 
vector both for deletion of the SacB gene from the RP24-238B22 clone and 
for modification of the caspase-8 gene.
Four modifications (A–D) were introduced (Fig. S6, scheme). (A) To 
monitor the expression of transgenic BAC in vivo, we placed an IRES se-
quence and the GFP ORF flanked by the two sequences corresponding to 
the FRT recombination site downstream of the stop codon of caspase-8. To 
introduce this sequence into the shuttle vector, we inserted the homology 
arms upstream and downstream of the stop codon (BoxA and BoxB; Fig. S5, 
scheme), cloned from the RP24-238B22 DNA by PCR, into the SalI–EcoRI 
and SpeI–NotI sites of the pBC FRT-IRES/GFP-FRT vector. The AF-AR 
and BF-BR oligonucleotides were used for generation of the Caspase-8 FRT-
IRES-GFP construct, and the AF-AR2 and BR-BR oligonucleotides were 
used for generation of the Caspase-8/T7 tag/FRT-IRES-GFP construct. The 
composite insert was then transferred to the shuttle vector. (B) To aid the 
monitoring of transgenic BAC expression, we fused the T7 epitope tag 
(MASMTGGQQMG) to the C terminus of caspase-8 by introducing the T7 
coding sequence to the EcoRI site in pBC FRT-IRES/GFP-FRT contain-
ing BoxA (derived from the AF-AR2 PCR product) and BoxB of (A). 
(C) To facilitate genotyping of the transgenic mice, we exchanged a 20-nt 
sequence within the first caspase-8 intron for a unique sequence (with equal 
nucleotide proportions). BoxC and BoxD were amplified by the use of prim-
ers CF-CR and DF-DR, respectively. We then fused these two PCR prod-
ucts by using them as templates in a second PCR, in which the CF and DR 
primers were used.
The data presented in this study were obtained with mice that express 
the  BAC  with  all  of  these  three  (A–C)  modifications.  Several  distinct 
mouse strains harboring the WT BAC and two strains harboring the mu-
tant BAC (see Generation and analysis of BAC-transgenic mouse) were 
generated. Identical findings were obtained with mice expressing BAC 
clones in which only the first modification (IRES/GFP) was introduced. 
(D) A catalytically inactive caspase-8 BAC transgenic mouse was generated 
by replacement of the active-site cysteine at position 362 with serine 
(C362S). BoxI and BoxJ, which border this sequence, were amplified and 
fused by PCR using primers Box1S-IR and JF-Box2AS. All of the modifi-
cation cassettes (A–D) were cloned into the AscI–NotI sites of the pDelsac 
shuttle vector.
500 ng of the shuttle vector was transformed into 50 µl of electrocom-
petent BAC-containing bacteria using a MicroPulser Electroporator (Bio-
Rad Laboratories) at 1.8 kV. After electroporation, the cells were incubated 
for 1 h at 37°C in 1 ml of SOC medium and then selected in LB medium 
containing 12.5 µg/ml chloramphenicol and 30 µg/ml ampicillin overnight. 
The cells were diluted and grown on solid LB medium containing 12.5 µg/ml 
chloramphenicol and 50 µg/ml ampicillin. Co-integrates were identified by 
direct PCR on individual colonies.
Two or three positive bacterial colonies of each kind were then cul-
tured in 5% sucrose to select for resolved BACs, and this was followed by 
further selection in which we picked ampicillin-sensitive colonies. Positive 
colonies were validated by direct PCR (TB3F-TB3R and TB4F-TB4R 
for AB or ATBCD and 1130F-1370R and MutCF-1370R for CD) and for 
IJ by HindIII restriction analysis after PCR performed with the IF2-JR1 
primer pair.
Isolation of BAC DNA for microinjection. BAC DNA was isolated by 
double acetate precipitation and cesium chloride gradient ultracentrifuga-2176 ROLE OF CASPASE-8 IN THE EPIDERMIS | Kovalenko et al.
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